296 related articles for article (PubMed ID: 15246280)
1. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
[TBL] [Abstract][Full Text] [Related]
4. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Hirao L; Isaacs SN; Moss B; Eisenberg RJ; Cohen GH
J Virol; 2005 May; 79(10):6260-71. PubMed ID: 15858010
[TBL] [Abstract][Full Text] [Related]
5. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
Law M; Smith GL
Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD
J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325
[TBL] [Abstract][Full Text] [Related]
7. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
Engelstad M; Smith GL
Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
[TBL] [Abstract][Full Text] [Related]
8. Extracellular enveloped vaccinia virus escapes neutralization.
Ichihashi Y
Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
[TBL] [Abstract][Full Text] [Related]
9. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
Viner KM; Isaacs SN
Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
[TBL] [Abstract][Full Text] [Related]
10. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
Jones-Trower A; Garcia A; Meseda CA; He Y; Weiss C; Kumar A; Weir JP; Merchlinsky M
Virology; 2005 Dec; 343(1):128-40. PubMed ID: 16165184
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response.
Stern RJ; Thompson JP; Moyer RW
Virology; 1997 Jun; 233(1):118-29. PubMed ID: 9201221
[TBL] [Abstract][Full Text] [Related]
12. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
Kaufman DR; Goudsmit J; Holterman L; Ewald BA; Denholtz M; Devoy C; Giri A; Grandpre LE; Heraud JM; Franchini G; Seaman MS; Havenga MJ; Barouch DH
J Virol; 2008 Jul; 82(14):6829-37. PubMed ID: 18448519
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
Herrera E; Lorenzo MM; Blasco R; Isaacs SN
J Virol; 1998 Jan; 72(1):294-302. PubMed ID: 9420227
[TBL] [Abstract][Full Text] [Related]
14. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.
Clark KM; Johnson JB; Kock ND; Mizel SB; Parks GD
Virology; 2011 Oct; 419(2):97-106. PubMed ID: 21885079
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail.
Lorenzo MM; Herrera E; Blasco R; Isaacs SN
Virology; 1998 Dec; 252(2):450-7. PubMed ID: 9878625
[TBL] [Abstract][Full Text] [Related]
16. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
[TBL] [Abstract][Full Text] [Related]
17. The effects of targeting the vaccinia virus B5R protein to the endoplasmic reticulum on virus morphogenesis and dissemination.
Mathew EC; Sanderson CM; Hollinshead R; Hollinshead M; Grimley R; Smith GL
Virology; 1999 Dec; 265(1):131-46. PubMed ID: 10603324
[TBL] [Abstract][Full Text] [Related]
18. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
[TBL] [Abstract][Full Text] [Related]
19. An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model.
Law M; Pütz MM; Smith GL
J Gen Virol; 2005 Apr; 86(Pt 4):991-1000. PubMed ID: 15784892
[TBL] [Abstract][Full Text] [Related]
20. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.
Mathew E; Sanderson CM; Hollinshead M; Smith GL
J Virol; 1998 Mar; 72(3):2429-38. PubMed ID: 9499104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
